[144] Idexx Laboratories Inc SEC Filing

Rhea-AI Filing Summary

Form 144 summary for IDEXX Laboratories, Inc. (IDXX)

This Form 144 reports a proposed sale of 7,143 shares of Common stock through Morgan Stanley Smith Barney LLC on NASDAQ with an aggregate market value of $4,503,160.87. Shares outstanding are listed as 80,004,694. The approximate date of sale is 08/06/2025.

The securities were acquired by stock option exercise on 08/06/2025 from the issuer and payment is listed as cash. The filing states "Nothing to Report" for securities sold during the past three months. Several filer and issuer contact fields (CIK, submission contact name/phone/email, date of notice, signature) are not provided in the extract.

Positive

• Proposed sale quantity disclosed: 7,143 shares listed for sale under Rule 144
• Aggregate market value provided: $4,503,160.87
• Acquisition details provided: Stock option exercise on 08/06/2025 with cash payment
• No recent disposals: "Nothing to Report" for securities sold during the past three months

Negative

• Filer identification fields missing in this extract: CIK and submission contact information not provided
• Administrative fields blank: Date of Notice and signature details are not populated in the provided content

Insights

Financial Analyst

TL;DR: Routine option exercise and Rule 144 sale of 7,143 shares; limited market or valuation impact given size and disclosed details.

The filing documents a standard Rule 144 notice for the proposed sale of 7,143 common shares valued at $4,503,160.87, transacted through Morgan Stanley Smith Barney LLC on 08/06/2025. The shares were acquired via a stock option exercise on the same date and paid in cash. The filing notes "Nothing to Report" for sales in the prior three months. For investors this appears to be a routine insider liquidity event rather than a material operational disclosure.

Corporate Governance Expert

TL;DR: Disclosure follows Rule 144 format but the extract omits several identifying fields and the notice date/signature in this copy.

The form specifies the class, broker, number of shares, aggregate market value, acquisition method (stock option exercise) and payment method (cash). However, key administrative fields in the provided extract—such as filer CIK and submission contact details and the Date of Notice/signature block—are not populated here. The omission limits independent verification and timing clarity from this excerpt but does not contradict the core transaction details disclosed.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7143	4503160.87	80004694	08/06/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/06/2025	Stock Option Exercise	Issuer			7143	08/06/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did IDEXX (IDXX) disclose in this Form 144?

The filing discloses a proposed sale of 7,143 common shares via Morgan Stanley Smith Barney LLC on 08/06/2025 on NASDAQ with aggregate market value $4,503,160.87 and 80,004,694 shares outstanding.

When is the approximate date of the proposed sale reported on the Form 144?

The approximate date of sale is listed as 08/06/2025.

How were the securities acquired according to the filing?

The securities were acquired by stock option exercise on 08/06/2025 from the issuer and payment is listed as cash.

Were there any securities sold in the past three months by the filing person?

The filing states "Nothing to Report" for securities sold during the past three months.

Which broker is named on the Form 144 for the sale?

The broker listed is Morgan Stanley Smith Barney LLC Executive Financial Services, 1 New York Plaza 8th Floor New York NY 10004.